Verition Fund Management
MNTA

Verition Fund Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Verition Fund Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,725
Closed -$405K – 1549
2020
Q3 		$405K Buy
+7,725
New +$320K 0.01% 660

Verition Fund Management's MNTA Position: Q4 2020 in Review

Verition Fund Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 7,725 shares — an estimated $405K sold.

Verition Fund Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $405K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Verition Fund Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Verition Fund Management sold 7,725 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $405K.
  • Verition Fund Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Verition Fund Management's Momenta Pharmaceuticals, Inc. position peaked at $405K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Verition Fund Management's 13F filing for Q4 2020, filed 16 Feb 2021.